Ginsenoside Rb2

• CAT Number: I000420
• CAS Number: 11021-13-9
• Molecular Formula: C53H90O22
• Molecular Weight: 1079.30
• Purity: ≥95%
• Synonyms: NSC 308878
• Target: Metabolic Enzyme/Protease
• Solubility: 10 mM in water
• Storage: Store at -20°C
• IUPAC Name: (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
• InChI: InChI=1S/C53H90O22/c1-23(2)10-9-14-53(8,75-47-43(67)39(63)37(61)29(72-47)22-69-45-41(65)34(58)26(57)21-68-45)24-11-16-52(7)33(24)25(56)18-31-50(5)15-13-32(49(3,4)30(50)12-17-51(31,52)6)73-48-44(40(64)36(60)28(20-55)71-48)74-46-42(66)38(62)35(59)27(19-54)70-46/h10,24-48,54-67H,9,11-22H2,1-8H3/t24-,25+,26-,27+,28+,29+,30-,31+,32-,33-,34-,35+,36+,37+,38-,39-,40-,41+,42+,43+,44+,45-,46-,47-,48-,50-,51+,52+,53-/m0/s1
• InChIKey: NODILNFGTFIURN-GZPRDHCNSA-N
• SMILES: CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@H](CO8)O)O)O)O)O)O)C

Ginsenoside Rb2（Cat No.:I000420）is a bioactive saponin derived from Panax ginseng, known for its potential therapeutic properties. This compound has been extensively studied for its antioxidant, anti-inflammatory, and neuroprotective effects. Ginsenoside Rb2 is believed to modulate various biological processes, including the regulation of blood glucose levels and the enhancement of cognitive function. It also shows promise in protecting against oxidative stress and supporting cardiovascular health. With its multiple pharmacological activities, Ginsenoside Rb2 serves as a valuable compound in pharmaceutical and nutraceutical research for the treatment of various conditions.

Reference

[1]. Huang Q, et al. Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis. Bone. 2014 Sep;66:306-14.

[2]. Yoo YC, et al. Protective effect of ginsenoside-Rb2 from Korean red ginseng on the lethal infection of haemagglutinating virus of Japan in mice. J Ginseng Res. 2013 Mar;37(1):80-6.

[3]. Lim HJ, et al. Inhibitory effects of ginsenoside-rb2 on nicotinic stimulation-evoked catecholamine secretion. Korean J Physiol Pharmacol. 2014 Oct;18(5):431-9.